The sleep study market size is estimated to be worth US$ 6,754.2 million in 2024. The sleep study industry is anticipated to surpass US$ 12,678.6 million by 2034. The increasing prevalence of sleep disorders and awareness regarding their adverse health effects are major drivers propelling the adoption of sleep studies.
The demand for sleep study is predicted to rise at a CAGR of 6.50% through 2034. As awareness grows about the importance of quality sleep for overall well-being, more individuals seek professional diagnosis and treatment through sleep study.
Attributes | Details |
---|---|
Sleep Study Market Value for 2024 | US$ 6,754.2 million |
Sleep Study Market Value for 2034 | US$ 12,678.6 million |
Sleep Study Market Forecast CAGR for 2024 to 2034 | 6.50% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Historical CAGR | 8.50% |
---|---|
Forecast CAGR | 6.50% |
The sleep study industry has shown a significant historical CAGR of 8.50%, indicating robust expansion over the specified period. This rapid growth can be attributed to several key factors, including increasing awareness about the importance of sleep health, rising prevalence of sleep disorders, advancements in sleep study technologies, and growing investment in healthcare infrastructure.
The forecasted CAGR for the sleep study market is slightly moderate at 6.50%. Several factors may have influenced this decrease in the projected growth rate. One possible factor is market saturation, as the initial surge in demand for sleep study may have plateaued over time. Additionally, regulatory challenges, reimbursement issues, and competition from alternative diagnostic methods could have impacted market growth.
Looking ahead, the market is expected to continue growing steadily, albeit at a slightly reduced rate. Factors such as ongoing research and development efforts to improve sleep study technologies, increasing adoption of telemedicine solutions, and rising awareness campaigns about sleep disorders are anticipated to support market expansion.
Increasing awareness of the importance of sleep for overall health and well-being is fueling interest in sleep studies among both individuals and healthcare providers, leading to higher demand for sleep assessment services.
The expansion of telemedicine services allows individuals to undergo sleep study remotely, eliminating the need for in-person visits to sleep centers and improving access to sleep assessment services, especially in underserved areas.
Home sleep testing is becoming increasingly popular as it is more convenient and cost-effective than in-lab sleep study. This trend is expected to continue as technology improves and becomes more accessible.
There is a growing demand for personalized treatment plans for sleep disorders. Sleep studies can help providers create customized treatment plans based on individual patient needs.
Reimbursement policies for sleep study are evolving, with many insurance providers covering the cost of sleep study. This is driving the adoption of sleep studies and is expected to continue to do so in the forecast period.
This section provides detailed insights into specific segments in the sleep study industry.
Top Testing Services | In-Lab Testing |
---|---|
Market Share in 2024 | 61% |
In-lab testing emerges as the leading category, capturing a projected 61% market share in 2024. Its growth can be attributed to several factors:
Dominating Indication Segment | Obstructive Sleep Apnea |
---|---|
Market Share in 2024 | 41% |
Obstructive sleep apnea (OSA) is expected to be the dominant indication segment in 2024, holding a projected market share of 41%. This dominance is driven by:
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The section analyzes the sleep study market across key countries, including the United States, United Kingdom, Thailand, India, and Germany. The analysis delves into the specific factors driving the demand for sleep studies in these countries.
Countries | CAGR |
---|---|
United States | 5.4% |
United Kingdom | 7.50% |
Thailand | 12.5% |
India | 9.81% |
Germany | 5.17% |
The sleep study industry in the United States is projected to rise at a CAGR of 5.4% through 2034.
The sleep study industry in the United Kingdom is likely to rise at a CAGR of 7.50% through 2034.
Thailand’s sleep study industry is anticipated to witness expansion at a CAGR of 12.5% through 2034.
India's sleep study industry is projected to rise at a CAGR of 9.81% through 2034.
Germany's sleep study market is expected to rise at a 5.17% CAGR through 2034.
Traditional sleep labs, often backed by major healthcare institutions, hold a strong market position. However, smaller, independent sleep clinics are emerging, offering competitive pricing and flexible scheduling options. This necessitates established players to modernize their facilities and services to remain competitive.
Technological advancements are shaping the competitive landscape. Players offering home sleep testing (HST) kits and cloud-based platforms for data analysis are gaining traction, providing patients with convenient and cost-effective alternatives to in-lab study. Established players need to adopt these technologies and invest in research & development to maintain their edge.
Collaboration holds significant potential. Partnerships between sleep clinics and healthcare providers facilitate referrals and improve patient access to sleep study. Additionally, collaborations with technology companies can accelerate innovation and enhance the patient experience through digital tools and data integration.
Recent Developments in the Sleep Study Industry
The sleep study market is projected to expand at a CAGR of 6.50% between 2024 and 2034.
The in-lab testing segment is predicted to dominate the industry.
The top 3 sleep study providers are Circle Health Group, Cleveland Clinic, and Competence Center of Sleep Medicine.
The sleep study market is anticipated to surpass US$ 12,678.6 million by 2034.
Increased awareness about the importance of sleep health and the rising prevalence of sleep disorders are driving the demand for sleep study.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Testing Services 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Testing Services, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Testing Services, 2024 to 2034 5.3.1. Home Sleep Testing 5.3.2. In-Lab Testing 5.3.2.1. Polysomnography (PSG) Testing 5.3.2.2. CPAP/ BiPAP Titration 5.3.2.3. Split Night Polysomnography 5.3.2.4. Multiple Sleep Latency Test (MSLT) 5.3.2.5. Maintenance of Wakefulness Test (MWT) 5.3.2.6. Epilepsy Monitoring 5.4. Y-o-Y Growth Trend Analysis By Testing Services, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Testing Services, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Indication, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication, 2024 to 2034 6.3.1. Obstructive Sleep Apnoea 6.3.2. Insomnia 6.3.3. Restless Leg Syndrome 6.3.4. Circadian Rhythm Sleeping Disorders 6.3.5. Narcolepsy 6.3.6. Rapid eye movement (REM) Sleep Disorders 6.3.7. Periodic Limb Movement Disorders 6.3.8. Bruxism 6.4. Y-o-Y Growth Trend Analysis By Indication, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Indication, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2019 to 2023 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2024 to 2034 7.3.1. Hospital Settings 7.3.2. Sleep Testing Centres 7.3.3. Home Care Settings 7.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023 7.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Testing Services 9.2.3. By Indication 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Testing Services 9.3.3. By Indication 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Testing Services 10.2.3. By Indication 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Testing Services 10.3.3. By Indication 10.3.4. By End User 10.4. Key Takeaways 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. UK 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Testing Services 11.2.3. By Indication 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Testing Services 11.3.3. By Indication 11.3.4. By End User 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Testing Services 12.2.3. By Indication 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Testing Services 12.3.3. By Indication 12.3.4. By End User 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Testing Services 13.2.3. By Indication 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Testing Services 13.3.3. By Indication 13.3.4. By End User 13.4. Key Takeaways 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Testing Services 14.2.3. By Indication 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Testing Services 14.3.3. By Indication 14.3.4. By End User 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Testing Services 15.2.3. By Indication 15.2.4. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Testing Services 15.3.3. By Indication 15.3.4. By End User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Market Share Analysis, 2023 16.1.1.1. By Testing Services 16.1.1.2. By Indication 16.1.1.3. By End User 16.2. Canada 16.2.1. Market Share Analysis, 2023 16.2.1.1. By Testing Services 16.2.1.2. By Indication 16.2.1.3. By End User 16.3. Brazil 16.3.1. Market Share Analysis, 2023 16.3.1.1. By Testing Services 16.3.1.2. By Indication 16.3.1.3. By End User 16.4. Mexico 16.4.1. Market Share Analysis, 2023 16.4.1.1. By Testing Services 16.4.1.2. By Indication 16.4.1.3. By End User 16.5. Germany 16.5.1. Market Share Analysis, 2023 16.5.1.1. By Testing Services 16.5.1.2. By Indication 16.5.1.3. By End User 16.6. UK 16.6.1. Market Share Analysis, 2023 16.6.1.1. By Testing Services 16.6.1.2. By Indication 16.6.1.3. By End User 16.7. France 16.7.1. Market Share Analysis, 2023 16.7.1.1. By Testing Services 16.7.1.2. By Indication 16.7.1.3. By End User 16.8. Spain 16.8.1. Market Share Analysis, 2023 16.8.1.1. By Testing Services 16.8.1.2. By Indication 16.8.1.3. By End User 16.9. Italy 16.9.1. Market Share Analysis, 2023 16.9.1.1. By Testing Services 16.9.1.2. By Indication 16.9.1.3. By End User 16.10. Poland 16.10.1. Market Share Analysis, 2023 16.10.1.1. By Testing Services 16.10.1.2. By Indication 16.10.1.3. By End User 16.11. Russia 16.11.1. Market Share Analysis, 2023 16.11.1.1. By Testing Services 16.11.1.2. By Indication 16.11.1.3. By End User 16.12. Czech Republic 16.12.1. Market Share Analysis, 2023 16.12.1.1. By Testing Services 16.12.1.2. By Indication 16.12.1.3. By End User 16.13. Romania 16.13.1. Market Share Analysis, 2023 16.13.1.1. By Testing Services 16.13.1.2. By Indication 16.13.1.3. By End User 16.14. India 16.14.1. Market Share Analysis, 2023 16.14.1.1. By Testing Services 16.14.1.2. By Indication 16.14.1.3. By End User 16.15. Bangladesh 16.15.1. Market Share Analysis, 2023 16.15.1.1. By Testing Services 16.15.1.2. By Indication 16.15.1.3. By End User 16.16. Australia 16.16.1. Market Share Analysis, 2023 16.16.1.1. By Testing Services 16.16.1.2. By Indication 16.16.1.3. By End User 16.17. New Zealand 16.17.1. Market Share Analysis, 2023 16.17.1.1. By Testing Services 16.17.1.2. By Indication 16.17.1.3. By End User 16.18. China 16.18.1. Market Share Analysis, 2023 16.18.1.1. By Testing Services 16.18.1.2. By Indication 16.18.1.3. By End User 16.19. Japan 16.19.1. Market Share Analysis, 2023 16.19.1.1. By Testing Services 16.19.1.2. By Indication 16.19.1.3. By End User 16.20. South Korea 16.20.1. Market Share Analysis, 2023 16.20.1.1. By Testing Services 16.20.1.2. By Indication 16.20.1.3. By End User 16.21. GCC Countries 16.21.1. Market Share Analysis, 2023 16.21.1.1. By Testing Services 16.21.1.2. By Indication 16.21.1.3. By End User 16.22. South Africa 16.22.1. Market Share Analysis, 2023 16.22.1.1. By Testing Services 16.22.1.2. By Indication 16.22.1.3. By End User 16.23. Israel 16.23.1. Market Share Analysis, 2023 16.23.1.1. By Testing Services 16.23.1.2. By Indication 16.23.1.3. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Testing Services 17.3.3. By Indication 17.3.4. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Circle Health Group 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Cleveland Clinic 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. USA Sleep Diagnostic 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Imperial College Healthcare NHS Trust 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Interdisciplinary Center of Sleep Medicine 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. International Institute of Sleep 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Koninklijke Philips N.V. 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Korea University Medicine 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. London Sleep Centre 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. MedStar Health 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.11. Millennium Sleep Lab 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports